{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T11:14:55Z","timestamp":1723288495552},"reference-count":53,"publisher":"Massachusetts Medical Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2021,2,25]]},"DOI":"10.1056\/nejmcpc2027089","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T22:02:22Z","timestamp":1614204142000},"page":"745-753","source":"Crossref","is-referenced-by-count":3,"title":["Case 6-2021: A 65-Year-Old Man with Eye Pain and Decreased Vision"],"prefix":"10.1056","volume":"384","author":[{"given":"Marc A.","family":"Bouffard","sequence":"first","affiliation":[{"name":"From the Department of Neurology, Beth Israel Deaconess Medical Center (M.A.B.), the Departments of Neurology (B.K.C.), Radiology (J.M.R.), Neuro-oncology (I.C.A.-R.), and Pathology (L.R.M.), Massachusetts General Hospital, and the Departments of Neurology (B.K.C.), Radiology (J.M.R.), Neuro-oncology (I.C.A.-R.), and Pathology (L.R.M.), Harvard Medical School \u2014 all in Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart K.","family":"Chwalisz","sequence":"additional","affiliation":[{"name":"From the Department of Neurology, Beth Israel Deaconess Medical Center (M.A.B.), the Departments of Neurology (B.K.C.), Radiology (J.M.R.), Neuro-oncology (I.C.A.-R.), and Pathology (L.R.M.), Massachusetts General Hospital, and the Departments of Neurology (B.K.C.), Radiology (J.M.R.), Neuro-oncology (I.C.A.-R.), and Pathology (L.R.M.), Harvard Medical School \u2014 all in Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier M.","family":"Romero","sequence":"additional","affiliation":[{"name":"From the Department of Neurology, Beth Israel Deaconess Medical Center (M.A.B.), the Departments of Neurology (B.K.C.), Radiology (J.M.R.), Neuro-oncology (I.C.A.-R.), and Pathology (L.R.M.), Massachusetts General Hospital, and the Departments of Neurology (B.K.C.), Radiology (J.M.R.), Neuro-oncology (I.C.A.-R.), and Pathology (L.R.M.), Harvard Medical School \u2014 all in Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel C.","family":"Arrillaga-Romany","sequence":"additional","affiliation":[{"name":"From the Department of Neurology, Beth Israel Deaconess Medical Center (M.A.B.), the Departments of Neurology (B.K.C.), Radiology (J.M.R.), Neuro-oncology (I.C.A.-R.), and Pathology (L.R.M.), Massachusetts General Hospital, and the Departments of Neurology (B.K.C.), Radiology (J.M.R.), Neuro-oncology (I.C.A.-R.), and Pathology (L.R.M.), Harvard Medical School \u2014 all in Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas R.","family":"Massoth","sequence":"additional","affiliation":[{"name":"From the Department of Neurology, Beth Israel Deaconess Medical Center (M.A.B.), the Departments of Neurology (B.K.C.), Radiology (J.M.R.), Neuro-oncology (I.C.A.-R.), and Pathology (L.R.M.), Massachusetts General Hospital, and the Departments of Neurology (B.K.C.), Radiology (J.M.R.), Neuro-oncology (I.C.A.-R.), and Pathology (L.R.M.), Harvard Medical School \u2014 all in Boston."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"150","reference":[{"key":"e_1_3_4_2_2","first-page":"134","article-title":"Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function.","volume":"39","author":"Wall M","year":"1998","unstructured":"Wall M, White WN II. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci 1998;39:134-142.9430554","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1167\/iovs.14-14243","article-title":"Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).","volume":"55","author":"Keltner JL","year":"2014","unstructured":"Keltner JL, Johnson CA, Cello KE, Wall M. Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Invest Ophthalmol Vis Sci 2014;55:3200-3207.24781936","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1167\/iovs.18-26252","article-title":"Threshold static automated perimetry of the full visual field in idiopathic intracranial hypertension.","volume":"60","author":"Wall M","year":"2019","unstructured":"Wall M, Subramani A, Chong LX, et al. Threshold static automated perimetry of the full visual field in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 2019;60:1898-1905.31042797","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archopht.1993.01090020085029","article-title":"Baseline visual field profile of optic neuritis: the experience of the optic neuritis treatment trial.","volume":"111","author":"Keltner JL","year":"1993","unstructured":"Keltner JL, Johnson CA, Spurr JO, Beck RW. Baseline visual field profile of optic neuritis: the experience of the optic neuritis treatment trial. Arch Ophthalmol 1993;111:231-234.8431161","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis.","volume":"326","author":"Beck RW","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992;326:581-588.1734247","journal-title":"N Engl J Med"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic\u2019s syndrome).","volume":"53","author":"Wingerchuk DM","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 1999;53:1107-1114.10496275","journal-title":"Neurology"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses.","volume":"79","author":"Kleiter I","year":"2016","unstructured":"Kleiter I, Gahlen A, Borisow N, et al. Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses. Ann Neurol 2016;79:206-216.26537743","journal-title":"Ann Neurol"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome.","volume":"195","author":"Chen JJ","year":"2018","unstructured":"Chen JJ, Flanagan EP, Jitprapaikulsan J, et al. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol 2018;195:8-15.30055153","journal-title":"Am J Ophthalmol"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2. Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.","volume":"13","author":"Jarius S","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2. Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 2016;13:280-280.27793206","journal-title":"J Neuroinflammation"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0161-6420(02)01148-X","article-title":"Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy.","volume":"109","author":"Rizzo JF","year":"2002","unstructured":"Rizzo JF III, Andreoli CM, Rabinov JD. Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002;109:1679-1684.12208717","journal-title":"Ophthalmology"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archophthalmol.2007.26","article-title":"Clinical course of optic neuritis in patients with relapsing neuromyelitis optica.","volume":"126","author":"Papais-Alvarenga RM","year":"2008","unstructured":"Papais-Alvarenga RM, Carellos SC, Alvarenga MP, Holander C, Bichara RP, Thuler LCS. Clinical course of optic neuritis in patients with relapsing neuromyelitis optica. Arch Ophthalmol 2008;126:12-16.18195212","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1352458517731914","article-title":"Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.","volume":"24","author":"Sep\u00falveda M","year":"2018","unstructured":"Sep\u00falveda M, Sola-Valls N, Escudero D, et al. Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies. Mult Scler 2018;24:1753-1759.28920766","journal-title":"Mult Scler"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica.","volume":"6","author":"Wingerchuk DM","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805-815.17706564","journal-title":"Lancet Neurol"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archophthalmol.2012.1126","article-title":"Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.","volume":"130","author":"Merle H","year":"2012","unstructured":"Merle H, Olindo S, Jeannin S, et al. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica. Arch Ophthalmol 2012;130:858-862.22776923","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/WNO.0b013e318283c3ed","article-title":"Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system.","volume":"33","author":"Storoni M","year":"2013","unstructured":"Storoni M, Davagnanam I, Radon M, Siddiqui A, Plant GT. Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system. J Neuroophthalmol 2013;33:123-127.23609766","journal-title":"J Neuroophthalmol"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/WNO.0000000000000593","article-title":"Optic disc edema in glial fibrillary acidic protein autoantibody-positive meningoencephalitis.","volume":"38","author":"Chen JJ","year":"2018","unstructured":"Chen JJ, Aksamit AJ, McKeon A, et al. Optic disc edema in glial fibrillary acidic protein autoantibody-positive meningoencephalitis. J Neuroophthalmol 2018;38:276-281.29210929","journal-title":"J Neuroophthalmol"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/WCO.0000000000000676","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy.","volume":"32","author":"Kunchok A","year":"2019","unstructured":"Kunchok A, Zekeridou A, McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol 2019;32:452-458.30724768","journal-title":"Curr Opin Neurol"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/WNO.0000000000000842","article-title":"Enlarged and enhancing optic nerves in advanced glial fibrillary acidic protein meningoencephalomyelitis.","volume":"39","author":"White D","year":"2019","unstructured":"White D, Mollan SP, Ramalingam S, Nagaraju S, Hayton T, Jacob S. Enlarged and enhancing optic nerves in advanced glial fibrillary acidic protein meningoencephalomyelitis. J Neuroophthalmol 2019;39:411-415.31397693","journal-title":"J Neuroophthalmol"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","article-title":"Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.","volume":"54","author":"Cross SA","year":"2003","unstructured":"Cross SA, Salomao DR, Parisi JE, et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol 2003;54:38-50.12838519","journal-title":"Ann Neurol"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ophtha.2019.09.012","article-title":"Collapsin response-mediator protein 5-associated retinitis, vitritis, and optic disc edema.","volume":"127","author":"Cohen DA","year":"2020","unstructured":"Cohen DA, Bhatti MT, Pulido JS, et al. Collapsin response-mediator protein 5-associated retinitis, vitritis, and optic disc edema. Ophthalmology 2020;127:221-229.31676123","journal-title":"Ophthalmology"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12348-012-0079-5","article-title":"Clinical spectrum of tuberculous optic neuropathy.","volume":"2","author":"Davis EJ","year":"2012","unstructured":"Davis EJ, Rathinam SR, Okada AA, et al. Clinical spectrum of tuberculous optic neuropathy. J Ophthalmic Inflamm Infect 2012;2:183-189.22614321","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0039-6257(96)80004-X","article-title":"The spectrum of orbital aspergillosis: a clinicopathological review.","volume":"41","author":"Levin LA","year":"1996","unstructured":"Levin LA, Avery R, Shore JW, Woog JJ, Baker AS. The spectrum of orbital aspergillosis: a clinicopathological review. Surv Ophthalmol 1996;41:142-154.8890440","journal-title":"Surv Ophthalmol"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bjo.2003.021725","article-title":"Localised invasive sino-orbital aspergillosis: characteristic features.","volume":"88","author":"Sivak-Callcott JA","year":"2004","unstructured":"Sivak-Callcott JA, Livesley N, Nugent RA, Rasmussen SL, Saeed P, Rootman J. Localised invasive sino-orbital aspergillosis: characteristic features. Br J Ophthalmol 2004;88:681-687.15090423","journal-title":"Br J Ophthalmol"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1067\/mhn.2002.126587","article-title":"Rhino-orbital and rhino-orbito-cerebral mucormycosis.","volume":"127","author":"Talmi YP","year":"2002","unstructured":"Talmi YP, Goldschmied-Reouven A, Bakon M, et al. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg 2002;127:22-31.12161726","journal-title":"Otolaryngol Head Neck Surg"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00041327-199406000-00002","article-title":"Natural history of nonarteritic anterior ischemic optic neuropathy.","volume":"14","author":"Arnold AC","year":"1994","unstructured":"Arnold AC, Hepler RS. Natural history of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 1994;14:66-69.7951929","journal-title":"J Neuroophthalmol"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis.","volume":"125","author":"Hayreh SS","year":"1998","unstructured":"Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998;125:509-520.9559737","journal-title":"Am J Ophthalmol"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2009-05-174359","article-title":"How I treat Waldenstr\u00f6m macroglobulinemia.","volume":"114","author":"Treon SP","year":"2009","unstructured":"Treon SP. How I treat Waldenstr\u00f6m macroglobulinemia. Blood 2009;114:2375-2385.19617573","journal-title":"Blood"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/WNO.0000000000000447","article-title":"Diagnosing light chain amyloidosis on temporal artery biopsies for suspected giant cell arteritis.","volume":"37","author":"Ghinai RAM","year":"2017","unstructured":"Ghinai RAM, Mahmood S, Mukonoweshuro P, Webber S, Wechalekar AD, Moore SE. Diagnosing light chain amyloidosis on temporal artery biopsies for suspected giant cell arteritis. J Neuroophthalmol 2017;37:34-39.27556960","journal-title":"J Neuroophthalmol"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","article-title":"Cryoglobulinemia vasculitis.","volume":"128","author":"Cacoub P","year":"2015","unstructured":"Cacoub P, Comarmond C, Domont F, Savey L, Saadoun D. Cryoglobulinemia vasculitis. Am J Med 2015;128:950-955.25837517","journal-title":"Am J Med"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MD.0b013e318288925c","article-title":"The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases.","volume":"92","author":"Terrier B","year":"2013","unstructured":"Terrier B, Karras A, Kahn J-E, et al. The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases. Medicine (Baltimore) 2013;92:61-68.23429354","journal-title":"Medicine (Baltimore)"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/WNO.0000000000000722","article-title":"Ischemic optic neuropathy secondary to intravascular lymphoma.","volume":"39","author":"Dinkin M","year":"2019","unstructured":"Dinkin M, Lavi E, Winterkorn J, Oliveira C, Merkler AE. Ischemic optic neuropathy secondary to intravascular lymphoma. J Neuroophthalmol 2019;39:313-318.30531633","journal-title":"J Neuroophthalmol"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/ajh.25254","article-title":"Predictors of symptomatic hyperviscosity in Waldenstr\u00f6m macroglobulinemia.","volume":"93","author":"Abeykoon JP","year":"2018","unstructured":"Abeykoon JP, Zanwar S, Ansell SM, et al. Predictors of symptomatic hyperviscosity in Waldenstr\u00f6m macroglobulinemia. Am J Hematol 2018;93:1384-1393.30121949","journal-title":"Am J Hematol"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/eye.2008.193","article-title":"Bilateral simultaneous central retinal vein occlusion secondary to hyperviscosity in Waldenstrom\u2019s macroglobulinaemia.","volume":"22","author":"Alexander P","year":"2008","unstructured":"Alexander P, Flanagan D, Rege K, Foss A, Hingorani M. Bilateral simultaneous central retinal vein occlusion secondary to hyperviscosity in Waldenstrom\u2019s macroglobulinaemia. Eye (Lond) 2008;22:1089-1092.18600248","journal-title":"Eye (Lond)"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bjo.67.2.102","article-title":"Irreversible visual loss in Waldenstr\u00f6m\u2019s macroglobulinaemia.","volume":"67","author":"Thomas EL","year":"1983","unstructured":"Thomas EL, Olk RJ, Markman M, Braine H, Patz A. Irreversible visual loss in Waldenstr\u00f6m\u2019s macroglobulinaemia. Br J Ophthalmol 1983;67:102-106.6401430","journal-title":"Br J Ophthalmol"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3816\/CLML.2011.n.043","article-title":"Novel diagnostic approaches in Bing-Neel syndrome.","volume":"11","author":"Ly KI","year":"2011","unstructured":"Ly KI, Fintelmann F, Forghani R, Schaefer PW, Hochberg EP, Hochberg FH. Novel diagnostic approaches in Bing-Neel syndrome. Clin Lymphoma Myeloma Leuk 2011;11:180-183.21856555","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/bjh.16167","article-title":"How we manage Bing-Neel syndrome.","volume":"187","author":"Castillo JJ","year":"2019","unstructured":"Castillo JJ, Treon SP. How we manage Bing-Neel syndrome. Br J Haematol 2019;187:277-285.31430829","journal-title":"Br J Haematol"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3324\/haematol.2016.147728","article-title":"Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.","volume":"102","author":"Minnema MC","year":"2017","unstructured":"Minnema MC, Kimby E, D\u2019Sa S, et al. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome. Haematologica 2017;102:43-51.27758817","journal-title":"Haematologica"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1309\/R01VXG46MFCDVNHL","article-title":"Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia: clinicopathologic features of 12 cases.","volume":"120","author":"Lin P","year":"2003","unstructured":"Lin P, Mansoor A, Bueso-Ramos C, Hao S, Lai R, Medeiros LJ. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia: clinicopathologic features of 12 cases. Am J Clin Pathol 2003;120:246-253.12931555","journal-title":"Am J Clin Pathol"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/00000478-200308000-00007","article-title":"Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients.","volume":"27","author":"Lin P","year":"2003","unstructured":"Lin P, Bueso-Ramos C, Wilson CS, Mansoor A, Medeiros LJ. Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients. Am J Surg Pathol 2003;27:1104-1113.12883242","journal-title":"Am J Surg Pathol"},{"key":"e_1_3_4_41_2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1200\/JCO.2007.15.1530","article-title":"Increased incidence of transformation and myelodysplasia\/acute leukemia in patients with Waldenstr\u00f6m macroglobulinemia treated with nucleoside analogs.","volume":"27","author":"Leleu X","year":"2009","unstructured":"Leleu X, Soumerai J, Roccaro A, et al. Increased incidence of transformation and myelodysplasia\/acute leukemia in patients with Waldenstr\u00f6m macroglobulinemia treated with nucleoside analogs. J Clin Oncol 2009;27:250-255.19064987","journal-title":"J Clin Oncol"},{"key":"e_1_3_4_42_2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bjh.13883","article-title":"Central nervous system involvement by Waldenstr\u00f6m macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.","volume":"172","author":"Castillo JJ","year":"2016","unstructured":"Castillo JJ, D\u2019Sa S, Lunn MP, et al. Central nervous system involvement by Waldenstr\u00f6m macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study. Br J Haematol 2016;172:709-715.26686858","journal-title":"Br J Haematol"},{"key":"e_1_3_4_43_2","first-page":"60","article-title":"Optic neuropathy in the context of leukemia or lymphoma: diagnostic approach to a neuro-oncologic emergency.","volume":"4","author":"Myers KA","year":"2017","unstructured":"Myers KA, Nikolic A, Romanchuk K, et al. Optic neuropathy in the context of leukemia or lymphoma: diagnostic approach to a neuro-oncologic emergency. Neurooncol Pract 2017;4:60-66.31386008","journal-title":"Neurooncol Pract"},{"key":"e_1_3_4_44_2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/WNO.0000000000000138","article-title":"Isolated optic nerve, chiasm, and tract involvement in Bing-Neel Syndrome.","volume":"34","author":"Hughes MS","year":"2014","unstructured":"Hughes MS, Atkins EJ, Cestari DM, Stacy RC, Hochberg F. Isolated optic nerve, chiasm, and tract involvement in Bing-Neel Syndrome. J Neuroophthalmol 2014;34:340-345.25409481","journal-title":"J Neuroophthalmol"},{"key":"e_1_3_4_45_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/WNO.0b013e3181dee96c","article-title":"Orbital involvement in Bing-Neel syndrome.","volume":"30","author":"Stacy RC","year":"2010","unstructured":"Stacy RC, Jakobiec FA, Hochberg FH, Hochberg EP, Cestari DM. Orbital involvement in Bing-Neel syndrome. J Neuroophthalmol 2010;30:255-259.20548243","journal-title":"J Neuroophthalmol"},{"key":"e_1_3_4_46_2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/WNO.0b013e31820ecbc1","article-title":"Orbital involvement in Bing-Neel syndrome.","volume":"31","author":"Doshi RR","year":"2011","unstructured":"Doshi RR, Silkiss RZ, Imes RK. Orbital involvement in Bing-Neel syndrome. J Neuroophthalmol 2011;31:94-95.21317736","journal-title":"J Neuroophthalmol"},{"key":"e_1_3_4_47_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1756285608101222","article-title":"Primary CNS lymphoma.","volume":"2","author":"Schlegel U","year":"2009","unstructured":"Schlegel U. Primary CNS lymphoma. Ther Adv Neurol Disord 2009;2:93-104.21180644","journal-title":"Ther Adv Neurol Disord"},{"key":"e_1_3_4_48_2","unstructured":"Swerdlow SH Campo E Harris NL et al. eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Vol. 2. Lyon France: IARC Press 2017 (https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/WHO-Classification-Of-Tumours-Of-Haematopoietic-And-Lymphoid-Tissues-2017)."},{"key":"e_1_3_4_49_2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom\u2019s Macroglobulinemia.","volume":"30","author":"Owen RG","year":"2003","unstructured":"Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom\u2019s Macroglobulinemia. Semin Oncol 2003;30:110-115.12720118","journal-title":"Semin Oncol"},{"key":"e_1_3_4_50_2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia.","volume":"367","author":"Treon SP","year":"2012","unstructured":"Treon SP, Xu L, Yang G, et al. MYD88 L265P somatic mutation in Waldenstr\u00f6m\u2019s macroglobulinemia. N Engl J Med 2012;367:826-833.22931316","journal-title":"N Engl J Med"},{"key":"e_1_3_4_51_2","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1002\/ajh.24279","article-title":"Efficacy of ibrutinib in the treatment of Bing-Neel syndrome.","volume":"91","author":"Cabannes-Hamy A","year":"2016","unstructured":"Cabannes-Hamy A, Lemal R, Goldwirt L, et al. Efficacy of ibrutinib in the treatment of Bing-Neel syndrome. Am J Hematol 2016;91:E17-E19.26689870","journal-title":"Am J Hematol"},{"key":"e_1_3_4_52_2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/bjh.14218","article-title":"Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome.","volume":"179","author":"Mason C","year":"2017","unstructured":"Mason C, Savona S, Rini JN, et al. Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome. Br J Haematol 2017;179:339-341.27409073","journal-title":"Br J Haematol"},{"key":"e_1_3_4_53_2","first-page":"8573105","article-title":"A case of Bing-Neel syndrome successfully treated with ibrutinib.","volume":"2018","author":"O\u2019Neil DS","year":"2018","unstructured":"O\u2019Neil DS, Francescone MA, Khan K, et al. A case of Bing-Neel syndrome successfully treated with ibrutinib. Case Rep Hematol 2018;2018:8573105-8573105.30228918","journal-title":"Case Rep Hematol"},{"key":"e_1_3_4_54_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood-2018-10-879593","article-title":"Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study.","volume":"133","author":"Castillo JJ","year":"2019","unstructured":"Castillo JJ, Itchaki G, Paludo J, et al. Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study. Blood 2019;133:299-305.30523119","journal-title":"Blood"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMcpc2027089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:37:25Z","timestamp":1711499845000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMcpc2027089"}},"subtitle":[],"editor":[{"given":"Richard C.","family":"Cabot","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Virginia M.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"David M.","family":"Dudzinski","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Meridale V.","family":"Baggett","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Dennis C.","family":"Sgroi","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Jo-Anne O.","family":"Shepard","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Kathy M.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Matthew B.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Emily K.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Tara","family":"Corpuz","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,2,25]]}},"alternative-id":["10.1056\/NEJMcpc2027089"],"URL":"https:\/\/doi.org\/10.1056\/nejmcpc2027089","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]}}}